CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

EXPANDED ROLE FOR TRANSOESOPHAGEAL ECHOCARDIOGRAPHY IN PERCATHETER CLOSURE OF ATRIAL SEPTAL DEFECTS.

R Graham*,  J Gelman, D McGaw, RW Harper.

Cardiology Unit, Monash Medical Centre and Centre for Heart and Chest Research, Monash University, Clayton, Victoria.

Transoesophageal echocardiography (TOE) constitutes an essential part of the percatheter closure of secundum atrial septal defects (ASD), with major procedural roles related to sizing of the defect and guiding device deployment.  Our experience of percatheter ASD closures performed in 31 patients [24 female, mean age 46 yrs] over a year period has, however, pointed to an expanded role for the use of TOE with such closures, which covers three broad areas.

1)      Closure of complex defects.   Our patient cohort has included three patients with a fenestrated aneurysmal septum, closed with an Amplatzer PFO closure device.  In these cases TOE confirmed passage of the delivery catheter across a central defect and ensured that the atrial discs covered the additional fenestrations. Another patient had two discrete secundum ASDs which were successfully closed with 2  Amplatzer devices.

2)      Detection of unexpected procedural complications.  In our patient series, TOE has detected unexpected events including the development of thrombus on the delivery catheter and herniation of the Chiari network into the left atrium after entanglement with the closure device.  In both cases, catheter withdrawal prevented further complications. In another instance, TOE revealed that the onset of haemodynamic instability during balloon sizing of an inferior ASD was related to obstruction of the inferior vena cava by the inflated balloon.

3)Long-term followup.  At our institution, a follow-up TOE is routinely performed at 1 and 12 months after ASD closure to confirm satisfactory device position and assess the degree of residual shunt.  However, in one patient of our series, a thrombus was detected on a closure device at the 1 TOE month study, which resolved after institution of anticoagulation therapy.

Conclusion: Increasing experience with the percatheter ASD closure technique has pointed to an expanded role for TOE, not only in the periprocedural, but also in the follow-up phase.

[ Back to 48th ASM Abstract Index ]


Med-E-Serv